NCT02078687

Brief Summary

This is a follow-up cohort study of 6 years old children born preterm in Denmark from 2004-2008, and at four different neonatal units. During hospitalisation they received breast milk with fortification. At time of discharge there were made 3 different nutrition groups; if possible they were randomised into one of two groups:

  1. 1.Breastfeeding solely
  2. 2.Breastfeeding with fortification
  3. 3.Preterm formula

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
239

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Oct 2010

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2010

Completed
3.4 years until next milestone

First Submitted

Initial submission to the registry

February 28, 2014

Completed
5 days until next milestone

First Posted

Study publicly available on registry

March 5, 2014

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2015

Completed
1.2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2016

Completed
Last Updated

October 27, 2016

Status Verified

October 1, 2016

Enrollment Period

4.5 years

First QC Date

February 28, 2014

Last Update Submit

October 26, 2016

Conditions

Keywords

very pretermnutrition6 year follow-upgrowthmetabolic syndromeallergydexa

Outcome Measures

Primary Outcomes (1)

  • Growth

    Measurement of weight at 6 years corrected age

    Follow-up at approximately 6 years corrected age

Secondary Outcomes (1)

  • Metabolic syndrome

    Follow-up at approximately 6 years corrected age

Other Outcomes (8)

  • Allergy

    Follow-up at approximately 6 years corrected age

  • Growth

    Follow-up at approximately 6 years corrected age

  • Growth

    Follow-up at approximately 6 years corrected age

  • +5 more other outcomes

Study Arms (3)

Group 1, HM

ACTIVE COMPARATOR

This group received breastfeeding (human milk, HM) solely throughout the 4 month of intervention. Randomisation for group 1 or group 2. Mothers own milk.

Dietary Supplement: Mothers own milk

Group 2, HMF

ACTIVE COMPARATOR

This group received mothers own milk with fortification (human milk fortification, HMF) throughout the 4 month intervention period. Randomisation for group 1 og group 2. Enfamil HM fortifier, Mead Johnson.

Dietary Supplement: Enfamil HM fortifier, Mead JohnsonDietary Supplement: Mothers own milk

Group 3, PF

ACTIVE COMPARATOR

This group received preterm formula (PF) throughout the intervention period of 4 month. This group was not randomised for ethical reasons. Enfalac Premature Formula, Mead Johnson Nutritionals

Dietary Supplement: Enfalac Premature Formula, Mead Johnson Nutritionals

Interventions

Enfamil was added to a small amount of mothers expressed milk and given in a bottle or with a small cup every day. Group 2 (HMF) received 5 packets each day for 4 month containing; 17.5 kcal, 1.375 g protein/ 5 packets

Also known as: Enfamil HM fortifier, Mead Johnson, Njimegen, Netherlands
Group 2, HMF

Group 3 received Enfalac containing: 68 kcal, 2 g protein, 7.4 g carbohydrate, 3.5 g fat/ 100 ml

Also known as: Enfalac PF, Mead Johnson Nutritionals, Njimegen, Netherlands
Group 3, PF
Mothers own milkDIETARY_SUPPLEMENT

Group 1 received mothers own milk without fortification

Group 1, HMGroup 2, HMF

Eligibility Criteria

Age6 Years - 8 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Participated in the original study when they were discharge from hospital
  • Parents accept of participation in the 6 year follow-up

You may not qualify if:

  • Participation not accepted by parents
  • Genetic diseases with influence on growth

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

HC Anderson Children´s Hospital, OUH

Odense, 5000, Denmark

Location

Related Publications (14)

  • Barker DJ. In utero programming of chronic disease. Clin Sci (Lond). 1998 Aug;95(2):115-28.

    PMID: 9680492BACKGROUND
  • Hofman PL, Regan F, Harris M, Robinson E, Jackson W, Cutfield WS. The metabolic consequences of prematurity. Growth Horm IGF Res. 2004 Jun;14 Suppl A:S136-9. doi: 10.1016/j.ghir.2004.03.029.

    PMID: 15135796BACKGROUND
  • Amesz EM, Schaafsma A, Cranendonk A, Lafeber HN. Optimal growth and lower fat mass in preterm infants fed a protein-enriched postdischarge formula. J Pediatr Gastroenterol Nutr. 2010 Feb;50(2):200-7. doi: 10.1097/MPG.0b013e3181a8150d.

    PMID: 19881394BACKGROUND
  • Hofman PL, Regan F, Jackson WE, Jefferies C, Knight DB, Robinson EM, Cutfield WS. Premature birth and later insulin resistance. N Engl J Med. 2004 Nov 18;351(21):2179-86. doi: 10.1056/NEJMoa042275.

    PMID: 15548778BACKGROUND
  • Siltanen M, Savilahti E, Pohjavuori M, Kajosaari M. Respiratory symptoms and lung function in relation to atopy in children born preterm. Pediatr Pulmonol. 2004 Jan;37(1):43-9. doi: 10.1002/ppul.10402.

    PMID: 14679488BACKGROUND
  • Liem JJ, Kozyrskyj AL, Huq SI, Becker AB. The risk of developing food allergy in premature or low-birth-weight children. J Allergy Clin Immunol. 2007 May;119(5):1203-9. doi: 10.1016/j.jaci.2006.12.671. Epub 2007 Mar 26.

    PMID: 17379288BACKGROUND
  • G. Zachariassen, J Færk mf. Nutrient-enrichment of human milk for preterm infants after hospital discharge - a randomized controlled trial. Pediatrics 2010.

    BACKGROUND
  • O'Connor DL, Khan S, Weishuhn K, Vaughan J, Jefferies A, Campbell DM, Asztalos E, Feldman M, Rovet J, Westall C, Whyte H; Postdischarge Feeding Study Group. Growth and nutrient intakes of human milk-fed preterm infants provided with extra energy and nutrients after hospital discharge. Pediatrics. 2008 Apr;121(4):766-76. doi: 10.1542/peds.2007-0054.

    PMID: 18381542BACKGROUND
  • Hack M, Schluchter M, Cartar L, Rahman M, Cuttler L, Borawski E. Growth of very low birth weight infants to age 20 years. Pediatrics. 2003 Jul;112(1 Pt 1):e30-8. doi: 10.1542/peds.112.1.e30.

    PMID: 12837903BACKGROUND
  • Farooqi A, Hagglof B, Sedin G, Gothefors L, Serenius F. Growth in 10- to 12-year-old children born at 23 to 25 weeks' gestation in the 1990s: a Swedish national prospective follow-up study. Pediatrics. 2006 Nov;118(5):e1452-65. doi: 10.1542/peds.2006-1069.

    PMID: 17079546BACKGROUND
  • De Curtis M, Pieltain C, Rigo J. Body composition in preterm infants fed standard term or enriched formula after hospital discharge. Eur J Nutr. 2002 Aug;41(4):177-82. doi: 10.1007/s00394-002-0374-2.

    PMID: 12242586BACKGROUND
  • Zachariassen G, Faerk J, Grytter C, Esberg BH, Hjelmborg J, Mortensen S, Thybo Christesen H, Halken S. Nutrient enrichment of mother's milk and growth of very preterm infants after hospital discharge. Pediatrics. 2011 Apr;127(4):e995-e1003. doi: 10.1542/peds.2010-0723. Epub 2011 Mar 14.

    PMID: 21402642BACKGROUND
  • Zachariassen G, Faerk J, Esberg BH, Fenger-Gron J, Mortensen S, Christesen HT, Halken S. Allergic diseases among very preterm infants according to nutrition after hospital discharge. Pediatr Allergy Immunol. 2011 Aug;22(5):515-20. doi: 10.1111/j.1399-3038.2010.01102.x. Epub 2011 Feb 20.

    PMID: 21332800BACKGROUND
  • Toftlund LH, Halken S, Agertoft L, Zachariassen G. Early nutrition and signs of metabolic syndrome at 6 y of age in children born very preterm. Am J Clin Nutr. 2018 May 1;107(5):717-724. doi: 10.1093/ajcn/nqy015.

MeSH Terms

Conditions

Metabolic SyndromeHypersensitivity

Condition Hierarchy (Ancestors)

Insulin ResistanceHyperinsulinismGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesImmune System Diseases

Study Officials

  • Gitte Zachariassen, Specialist

    HC Anderson Children´s Hospital, OUH, Denmark

    STUDY DIRECTOR
  • Susanne Halken, Professor

    HC Anderson children´s Hospital, OUH, Denmark

    STUDY CHAIR
  • Lone Agertoft, Specialist

    HC Anderson children´s Hospital, OUH, Denmark

    STUDY DIRECTOR
  • Line H Toftlund, MD

    HC Anderson children´s Hospital, OUH, Denmark

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PhD student, doctor in medicine

Study Record Dates

First Submitted

February 28, 2014

First Posted

March 5, 2014

Study Start

October 1, 2010

Primary Completion

April 1, 2015

Study Completion

June 1, 2016

Last Updated

October 27, 2016

Record last verified: 2016-10

Locations